Want to see SKIN full AI Analyst Report?
SKIN Stock Chart & Stats
$0.91
-$0.07(-3.95%)
At close: 4:00 PM EST
$0.91
-$0.07(-3.95%)
Day’s Range― - ―
52-Week Range$0.55 - $2.69
Previous CloseN/A
Volume138.49K
Average Volume (3M)1.04M
Market Cap
$109.36M
Enterprise Value$279.72
Total Cash (Recent Filing)$204.40M
Total Debt (Recent Filing)$367.20M
Price to Earnings (P/E)―
Beta2.10
Next Earnings
Aug 11, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding129,600,040
10 Day Avg. Volume926,645
30 Day Avg. Volume1,036,656
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)2.88
Price to Sales (P/S)0.58
P/FCF Ratio4.72
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$1.33Price Target Upside46.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.16
Revenue Forecast (FY)$289.47M
Bulls Say, Bears Say
Bulls Say
High Product-level MarginsSustained gross margins near 65% and a positive EBITDA margin indicate durable product economics from device-plus-consumable model. High margin mix gives the company room to invest in R&D and commercial fixes while still generating operating leverage as revenue recovers, supporting long-term profitability.
Recurring Installed-base RevenueA growing installed base and materially lower churn underpin recurring consumables and service revenue. This attachment-driven business creates predictable cash flow streams tied to usage, reducing reliance on new device sales and supporting revenue durability as commercialization improvements take hold over multiple quarters.
Positive Cash Generation And LiquidityConsistent positive operating and free cash flow provides practical ability to fund operations, capex, and near-term maturities. Coupled with a large cash balance reported at quarter-end, this cash generation supports deleveraging and gives management flexibility to implement commercial fixes without immediate external funding.
Bears Say
Very High LeverageExtremely elevated debt relative to equity constrains financial flexibility and raises refinancing risk if cash generation falters. Even with positive FCF, the company’s ability to rapidly deleverage is limited because operating cash covers only a small portion of total debt, making capital structure a persistent vulnerability.
Top-line Pressure And Regional WeaknessDeclining consumables and significant APAC weakness highlight structural revenue headwinds. Since consumables drive recurring sales, regional channel shifts and distributor transitions can depress attachment rates and slow revenue recovery, meaningful risks to sustainable top-line growth until commercial fixes and channel stabilization take effect.
Listing Risk And Commercial Leadership TurnoverA Nasdaq minimum-bid notice creates ongoing governance and financing uncertainty that can impair strategic options. Concurrent executive turnover in the revenue organization raises execution risk, potentially slowing recovery in device placements and sales effectiveness while management implements structural commercial changes.
Beauty Health News
SKIN FAQ
What was Beauty Health’s price range in the past 12 months?
Beauty Health lowest stock price was $0.55 and its highest was $2.69 in the past 12 months.
What is Beauty Health’s market cap?
Beauty Health’s market cap is $109.36M.
When is Beauty Health’s upcoming earnings report date?
Beauty Health’s upcoming earnings report date is Aug 11, 2026 which is in 21 days.
How were Beauty Health’s earnings last quarter?
Beauty Health released its earnings results on May 07, 2026. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.074 by $0.024.
Is Beauty Health overvalued?
According to Wall Street analysts Beauty Health’s price is currently Undervalued.
Does Beauty Health pay dividends?
Beauty Health does not currently pay dividends.
What is Beauty Health’s EPS estimate?
Beauty Health’s EPS estimate is -0.03.
How many shares outstanding does Beauty Health have?
Beauty Health has 129,600,040 shares outstanding.
What happened to Beauty Health’s price movement after its last earnings report?
Beauty Health reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.074. Following the earnings report the stock price went down -36.264%.
Which hedge fund is a major shareholder of Beauty Health?
Currently, no hedge funds are holding shares in SKIN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.33 (46.52% Upside)
$1.33 (46.52% Upside)
Blogger Sentiment
Bullish
SKIN Sentiment 100%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Increased
By 319.9K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-29.77%
Trailing 12-Months
Company Description
Beauty Health
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
SKIN Stock 12 Month Forecast
Average Price Target
$1.33
▲(46.52% Upside)
Technical Analysis
Ownership Overview
7.90% Insiders
11.12% Mutual Funds
0.52% Other Institutional Investors
77.36% Public Companies and
Individual Investors